Ambalal Sarabhai Enterprises Limited (BSE: 500009)
Health Care · Pharmaceuticals · IN
Rs40.29
+6.25% today · +14.0% 1Y
Ambalal Sarabhai Enterprises Limited (BSE: 500009) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $31.90M.
Over the last twelve months the share price has gained 14.0%, trading between 23.12 and 49.98.
Tweenvest scores Ambalal Sarabhai Enterprises Limited across four factors: quality 70/100, value 57/100, growth 27/100. Its strongest factor is quality.
500009 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $31.90M
- Revenue (TTM)
- $21.76M
- P/E
- 22.79
- EPS
- 1.77
- Dividend yield
- —
- Beta (5Y)
- 0.01
- 52-week high
- Rs49.98
- 52-week low
- Rs23.12
- Avg volume (3M)
- —
- Shares outstanding
- 76.63M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Regent Pacific Group LimitedSEHK: 575 | $32.54M | HK$0.88 | +3.55% |
| PRISM BioLab Co.,LTDTSE: 206A | $32.45M | ¥139.00 | -4.79% |
| SoftOx Solutions ASOB: SOFTX | $32.42M | Nkr0.12 | -1.85% |
| MYUNGMOON Pharm co.,LtdKOSE: A017180 | $31.98M | ₩1,286.00 | +1.02% |
| MIRA Pharmaceuticals, Inc.NasdaqCM: MIRA | $31.33M | $0.70 | -6.60% |
| BioNxt Solutions Inc.CNSX: BNXT | $31.00M | CA$0.33 | -14.47% |
| Sharp Therapeutics Corp.TSXV: SHRX | $30.85M | CA$— | — |
| Astal Laboratories LimitedBSE: 512600 | $30.84M | Rs68.14 | -2.01% |
Figures last refreshed Oct 11, 2026.